PATIENT CHARACTERISTICS AND RISK FACTORS CONTRIBUTING TO DISEASE PROGRESSION AMONG HOSPITALISED PATIENTS WITH COVID-19: LESSON FROM MALAYSIA

Author:

Othman Nurul Syafiqah,Che Suraya Zin ,Nor Hidayah Mohd Taufek

Abstract

Background: Patients who were hospitalised with severe COVID-19 infection could progress to severe conditions due to various factors, whereas some patients may recover to mild conditions quickly. There was limited information regarding characteristics and factors affecting disease progression in this population in Malaysia. This study aimed to investigate patient characteristics and risk factors contributing to disease progression among COVID-19 patients during hospitalisation. Methods: A retrospective cross-sectional study using electronic medical record data from COVID-19 patients admitted to two public hospitals in East Coast Malaysia from February 2020 to August 2021 was conducted. This study included patients with asymptomatic or mild condition (stage 1 – stage 3) upon hospital admission and progressed to severe condition (stage 4 – stage 5) during hospitalisation. Results: A total of 163 patients were included (57% male) with the age of (mean±SD, 62.3 ±14.0 years). Multivariable logistic regression associated with COVID-19 disease progression included elderly (OR, 1.06; 95% CI, 1.04, 1.08; p = ≤0.05), diabetes mellitus (OR, 2.27; 95% CI, 1.27, 4.06; p = 0.006), chronic kidney disease (OR, 4.87; 95% CI, 1.92, 12.38; p=0.001), and presented with more than three COVID-19 symptoms (OR, 9.80; 95% CI, 6.08-15.81, p = ≤0.05). Conclusion: Risk factors for COVID-19 disease progression included elderly patients, comorbidities of diabetes mellitus, chronic kidney disease or more than three COVID-19 symptoms. Close monitoring and early intervention should be implemented for these patients to prevent the disease progression and poor prognosis.

Publisher

IIUM Press

Reference36 articles.

1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Napoli RD. (2021). Features, Evaluation, and Treatment of Coronavirus (COVID-19). Treasure Island (FL): StatPearls Publishing. Available from https://www.ncbi.nlm.nih.gov/books/NBK554776/

2. Elflein J. (2021). Coronavirus (COVID-19) disease pandemic – statistics and facts. Statista. https://www.statista.com/topics/5994/the-coronavirus-disease-covid-19-outbreak/

3. Choi MH, Ahn H, Ryu HS, Kim B, Jang J, Jung M, Kim J, Jeong SH. (2020). Clinical characteristics and disease progression in early-stage COVID-19 patients in South Korea. Journal of Clinical Medicine, 9(6):1959. https://doi.org/10.3390%2Fjcm9061959

4. Centers for Disease Control and Prevention. (2021, February 12). Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html

5. Daniel, WW. (2005). Biostatistics: A foundation for analysis in the health sciences. John Wiley & Sons, Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3